| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.36 | 0.03 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.03 |